Method for quantifying modified peptides
The present invention provides a method for quantifying modified peptides in a sample, the method comprising: (a) obtaining peptides from the sample; (b) adding reference modified peptides to the peptides obtained in step (a) to produce a mixture of peptides and reference modified peptides; (c) carrying out mass spectrometry (MS) on said mixture of peptides and reference modified peptides to obtain data relating to the peptides in the sample; and (d) comparing the data relating to the peptides in the sample with data in a database of modified peptides using a computer program; wherein the database of modified peptides is compiled by a method comprising: (i) obtaining peptides from a sample; (ii) enriching modified peptides from the peptides obtained in step (i); (iii) carrying out liquid chromatography-tandem mass spectrometry (LC-MS/MS) on the enriched modified peptides obtained in step (ii); (iv) comparing the modified peptides detected in step (iii) to a known reference database in order to identify the modified peptides; and (v) compiling data relating to the modified peptides identified in step (iv) into a database.
1. A label-free method for quantifying post-translational protein modifications in a plurality of samples, each sample containing a mixture of proteins obtained from a biological sample, the method comprising:
(a) obtaining peptides from the mixture of proteins in each sample of the plurality of samples by a process comprising cleaving the mixture of proteins in each sample into peptides using a protease to obtain a plurality of peptide samples;
(b) enriching post-translationally modified peptides from each sample to obtain a plurality of enriched peptide samples, each sample being enriched for post-translationally modified peptides;
(c) carrying out liquid chromatography-mass spectrometry (LC-MS) on the plurality of enriched peptide samples and obtaining MS data for the peptides in each sample of the plurality of samples, said MS data including mass to charge (m/z) ratio, charge (z), and relative retention time;
(d) comparing the MS data obtained in step (c) to a known reference database in order to identify the post-translationally modified peptides;
(e) compiling a database consisting of the MS data for all peptides across the plurality of enriched post-translationally modified peptide samples;
(f) constructing extracted ion chromatograms (XICs) for each post-translationally modified peptide present in the database compiled in step (e) across the plurality of enriched peptide samples; and
(g) quantifying each post-translationally modified peptide in the database across the plurality of enriched peptide samples by determining the peak height or area of each XIC, thereby quantifying post-translational protein modifications in the plurality of samples containing mixtures of proteins.
2. The method of claim 1 , wherein the modified peptides are phosphorylated peptides.
3. The method of claim 1 , wherein the protease is selected from the group consisting of trypsin, chymotrypsin, Arg-C, pepsin, V8, Lys-C, Asp-C and AspN.
4. The method of claim 1 , wherein the step of cleaving the proteins into peptides comprises cleaving said proteins into peptides of 5 to 30 amino acids.
5. The method of claim 1 , wherein the step of enriching modified peptides is carried out using chromatography.
6. The method of claim 5 , wherein the chromatography is selected from the group consisting of immobilized metal ion affinity chromatography (IMAC), titanium dioxide (TiO 2 ) chromatography and zirconium dioxide (ZrO 2 ) chromatography.
7. The method of claim 1 , wherein the step of enriching post-translationally modified peptides is carried out using antibody-based methods.
8. The method of claim 1 , wherein said LC-MS is liquid-chromatography tandem mass spectrometry (LC-MS/MS).
9. The method of claim 1 , wherein the enriching step is carried out using multidimensional chromatography.
10. The method of claim 9 , wherein the multidimensional chromatography is carried out using strong cation exchange high performance liquid chromatography (SCX-HPLC), immobilized metal ion affinity chromatography (IMAC) and titanium dioxide (TiO 2 ) chromatography.
11. The method of claim 9 , wherein the multidimensional chromatography is carried out using anion exchange high performance liquid chromatography (SAX-HPLC), immobilized metal ion affinity chromatography (IMAC) and titanium dioxide (TiO 2 ) chromatography.
12. The method of claim 1 , wherein the biological sample is obtained from a bodily fluid, tissue, or cell line.